Universitätsklinikum Würzburg 

ZIM (Zentrum Innere Medizin)
Haus A3/A4 

Oberdürrbacherstr. 6

97080 Würzburg


Studien - Pilzinfektionen

Inf-Wü002: Evaluation of non-culture based tests, using bronchoalveolar lavage in triplicate testing and serum, to establish diagnosis of a pulmonary aspergillus disease.

MSD/Merck No. MK-5592-069: A Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults
EudraCT No.: 2011-003938-14 Identifier: NCT01782131

EORTC - 65091-06093: Empirical versus pre-emptive antifungal therapy of patients with haematological malignancies. A therapeutic open label phase III strategy study of the EORTC Infectious diseases and leukemia Groups.
EudraCT No. : 2010-020814-27 Identifier: NCT01288378

Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome®) for the Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukemia (ALL);
Protokoll Nr.: GS-EU-131-0247
EudraCT No.: 2010-019562-91 Identifier: NCT01259713


Basilea WSA-CS 003: Open Label Study of Isavuconazole in the Treatment of Patients With Aspergillosis and Renal Impairment or of Patients With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
EudraCT No.: 2006-005003-33 Identifier: NCT00634049

WSA-CS 008: A Phase III, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 versus Caspofungin Followed by Voriconazole regimen in the Treatment of Candidemia and other invasive Candida Infections.
EudraCT No.: 2006-003951-18 Identifier: NCT00413218

Prospective trial to evaluate pharmacokinetic, safety and efficacy of intermittent application of increased doses of caspofungin for antifungal prophylaxis in high risk patients. Identifier: NCT01318148EudraCT No.: 2009-015159-26
Phase II, IIT